Not applicableNot Yet RecruitingNCT06730802
What this trial is testing
Protective Effect of PCSK9 Inhibitor Against Negative Inflammatory Response and Organ Dysfunction After Coronary Artery Bypass Grafting (PANDA VIII)
Who this might be right for
Myocardial Ischaemic SyndromeCoronary Heart Disease
Nanjing Medical University 400